Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Disease	Cell Type	Therapeutic or Technology	Institution	Stage	Project Objective	Details
Heart Disease, Hypertension, pulmonary arterial, Pulmonary Hypertension	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Neurological Disorders, Spinal Cord Injury	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	UC Irvine		Pre-IND/IDE or Equivalent
Duchenne Muscular Dystrophy, Skeletal/Smooth Muscle disorders	Somatic Cell	Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	MyoGene Bio LLC		Pre-IND/IDE or Equivalent
B cell cancers, Blood Cancer, Cancer	Somatic Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCSF		Pre-IND/IDE or Equivalent
Genetic Disorder, Metabolic Disorders	Somatic Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Immusoft Corporation		Pre-IND/IDE or Equivalent
Heart Disease	iPS Cell	Biologic, Protein/peptide therapy, Therapeutic Approach	Regencor, Inc.		Pre-IND/IDE or Equivalent
Blood Disorders, IPEX Syndrome	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	ImmunoVec		Pre-IND/IDE or Equivalent
Heart Disease	Adult or Tissue Stem Cell	Antibody, Biologic, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Neurological Disorders, Stroke	iPS Cell	Donor cell therapy, Therapeutic Approach	PAVIR		Pre-IND/IDE or Equivalent
Cancer, Melanoma, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Blood Cancer, Cancer, Multiple Myeloma	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Brain Injury, hypoxic, ischemic, Neurological Disorders, Pediatrics	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Sanford-Burnham		Pre-IND/IDE or Equivalent
Blood Cancer, Cancer, Multiple Myeloma	Adult or Tissue Stem Cell	Personalized cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Neurological Disorders, Traumatic Brain Injury	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	UC Irvine		Pre-IND/IDE or Equivalent
Blood Disorders, Hyper IgM Syndrome, Immune Disease	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCLA		Pre-IND/IDE or Equivalent
Age-related macular degeneration, Vision Loss	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Stanford		Pre-IND/IDE or Equivalent
Bladder or Urinary Tract Disorder, Incontinence, Skeletal/Smooth Muscle disorders	iPS Cell	Personalized cell therapy, Therapeutic Approach	Stanford		Pre-IND/IDE or Equivalent
Intestinal Disease, Metabolic Disorders, Neurological Disorders, Pediatrics	iPS Cell	Donor cell therapy, Therapeutic Approach	CHLA		Pre-IND/IDE or Equivalent
Autoimmune Disorder, Lupus, Systemic Lupus Erythematosus (SLE)	iPS Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	Fate Therapeutics		Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML)	Somatic Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	Senti Bio		Clinical Trial, Phase 1 or Phase 1/2
Immune Disease		Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	ImmPACT-Bio, Inc.		Clinical Trial, Phase 2
			Nexcella, Inc.
Brain Cancer, Cancer, Solid Tumors	Somatic Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	UCSF		Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Parkinson's Disease	iPS Cell	Personalized cell therapy, Therapeutic Approach	Aspen Neuroscience		Clinical Trial, Phase 1 or Phase 1/2
Cancer, Solid Tumors	Somatic Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	Allogene Therapeutics		Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors		Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	UCSF		Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration, Vision Loss	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	Luxa Biotechnology		Clinical Trial, Phase 1 or Phase 1/2
Danon Disease, Metabolic Disorders, Pediatrics		Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	Rocket Pharmaceuticals, Inc.		Clinical Trial, Phase 2
Brain Cancer, Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Developmental Disorders, Neurological Disorders, Spina Bifida	Adult or Tissue Stem Cell	Donor cell therapy, Therapeutic Approach	UC Davis		Clinical Trial, Phase 2
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML)		Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	COH		Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Other		Gene Therapy (All), Gene Therapy, cell free, Nucleic acid based therapy, Therapeutic Approach	UCSD		Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration, Vision Loss	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	Regenerative Patch Technologies LLC		Clinical Trial, Phase 2
Cancer, Melanoma, Solid Tumors	Somatic Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS, Infectious Disease	Other		COH		Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease, Hearing Loss, Intellectual Disability, Metabolic Disorders, Neurological Disorders, Vision Loss	Somatic Cell	Personalized cell therapy, Therapeutic Approach	Immusoft Corporation		Clinical Trial, Phase 1 or Phase 1/2
Corneal Damage, Vision Loss	Adult or Tissue Stem Cell	Biologic, Exosomes based therapy, Therapeutic Approach	Combangio		Clinical Trial, Phase 2
Cancer, Solid Tumors		Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Eureka Therapeutics, Inc.		Clinical Trial, Phase 1 or Phase 1/2
B cell cancers, Blood Cancer, Cancer	Somatic Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	Angiocrine		Clinical Trial, Phase 3
Anemia, Blood Disorders	Adult or Tissue Stem Cell	Antibody, Biologic, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease, Osteoarthritis	Somatic Cell	Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	Genascence Corporation		Clinical Trial, Phase 1 or Phase 1/2
Cancer, Colon Cancer, Solid Tumors			Tachyon Therapeutics, Inc		Clinical Trial, Phase 1 or Phase 1/2
Anemia, Blood Disorders, Bone Marrow Transplant and Viral Infection	Adult or Tissue Stem Cell	Immune tolerance/management, Technology	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Anemia, Blood Disorders	Somatic Cell	Cell processing & handling, Immune tolerance/management, Technology	COH		Clinical Trial, Phase 1 or Phase 1/2
Epilepsy, Neurological Disorders	Embryonic Stem Cell	Donor cell therapy, Therapeutic Approach	Neurona Therapeutics		Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS, Infectious Disease		Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach	Excision BioTherapeutics		Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, IPEX Syndrome	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach	Stanford		Clinical Trial, Phase 1 or Phase 1/2
Bladder or Urinary Tract Disorder, Skeletal/Smooth Muscle disorders	Somatic Cell	Technology, Tissue engineering	Wake Forest University Health Sciences		Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors	Adult or Tissue Stem Cell	Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach	COH		Clinical Trial, Phase 1 or Phase 1/2
Cancer, Solid Tumors	Adult or Tissue Stem Cell	Personalized cell therapy, Therapeutic Approach	BioEclipse Therapeutics INC.		Clinical Trial, Phase 1 or Phase 1/2